ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
The FDA set an April 23, 2026 PDUFA date for subcutaneous isatuximab in relapsed/refractory multiple myeloma, following positive phase 3 trial results.
Read More
Pope Leo XIV’s decision to carry the full wooden cross through all 14 Stations at Rome’s Colosseum drew renewed attention to the connection between physical acts of religious devotion and spiritual wellness.
Read More
A VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.
Read More
Denali’s Avlayah reduced cerebrospinal fluid heparan sulfate by 91% in a Phase 1/2 trial for pediatric Hunter syndrome patients.
Read More
The CDC updated childhood vaccine guidelines, reducing routine immunizations from 17 to 11 diseases and shifting six vaccines to high-risk groups.
Read More
Linguists and style experts explained that “alternative” implies mutually exclusive choices, while “option” denotes any selectable possibility.
Read More
Congress enacted Most Favored Nation pricing for biologics and specialty drugs on May 12, 2025, aligning U.S. prices with lower international rates.
Read More
CMS finalized a 2.6% increase in Medicare hospital outpatient payment rates for 2026, affecting 4,000 hospitals and 6,000 surgical centers.
Read More
A study finds sarcopenic obesity, excess belly fat with low muscle, raises death risk by 83% in adults over 50.
Read More
The FDA proposed reclassifying Mycobacterium tuberculosis immunity tests from Class III to Class II devices with new special controls.
Read More
